| Trial ID: | L2207 |
| Source ID: | NCT00911625
|
| Associated Drug: |
0.5 Units/Kg Daily Insulin
|
| Title: |
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00911625/results
|
| Conditions: |
Type 2 Diabetes|Renal Insufficiency
|
| Interventions: |
DRUG: 0.5 units/kg daily insulin|DRUG: 0.25 units/kg daily insulin
|
| Outcome Measures: |
Primary: Average Blood Glucose Over 6 Days, Participants have their blood glucose measured daily for six days. The average blood glucose measure over all six days is compared between the two treatment cohorts., 6 Days | Secondary: The Number of Participants Who Experience at Least One Blood Glucose Level Below 70 Milligrams Per Deciliter, At the end of the study, the number of participants who experience at least one blood glucose level below 70 milligrams per deciliter (mg/dL) is compared between the two treatment cohorts, 6 Days
|
| Sponsor/Collaborators: |
Sponsor: Loyola University | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
114
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-01-21
|
| Completion Date: |
2011-06-30
|
| Results First Posted: |
2017-03-10
|
| Last Update Posted: |
2017-04-06
|
| Locations: |
Northwestern University Medical Center, Chicago, Illinois, 60611, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Loyola University Hospital, Maywood, Illinois, 60153, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00911625
|
